vimarsana.com
Home
Live Updates
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis : comparemela.com
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis
Met primary and Hepatic Encephalopathy endpoints in Phase 2 studyIncrease in Skeletal Muscle Index observed at Week 24 was maintained through 52 weeksParticipants on placebo increased SMI when...
Related Keywords
United States ,
Arunj Sanyal ,
Mahesh Patel ,
Jennifer Lai ,
Prnewswire Lipocine Inc ,
Stravitz Sanyal Institute For Liver Disease Metabolic Health ,
Lipocine Inc ,
Nasdaq ,
Virginia Commonwealth University ,
Skeletal Muscle Index ,
Overt Hepatic ,
For Placebo ,
During Stage ,
Through Week ,
Placebo Converted ,
Stravitz Sanyal Institute ,
Liver Disease ,
Metabolic Health ,
End Stage Liver Disease ,
Private Securities Litigation Reform Act ,
Markets ,
comparemela.com © 2020. All Rights Reserved.